About US
Contact us
-
GSK and Genmab obtain FDA clearance for Arzerra as first-line treatment for CLLGlaxoSmithKline (GSK) and Genmab have obtained US Food and Drug Administration (FDA) approval for Arzerra (ofatumumab) as first-line treatment in combination with chlorambucil for patients with chroni2014/4/23
-
The price is right for patient-switching on Biogen's new hemophilia med AlprolixWith a pair of long-actinghemophiliameds on the way, Biogen Idec ($BIIB) appears poised to shake up the market for the bleeding disease. And though recently approvedAlprolixhas yet to launch, it has a2014/4/22
-
Full steam ahead for Copaxone copies as SCOTUS denies Teva's bid for delayLast week, generics makers asked the Supreme Court to let them launch their copies of Teva's Copaxone while it hears the Israeli company's appeal over the drug's patents. Now, they'll likely get that2014/4/22
-
Volasertib​, Boehringer Ingelheim'​s Investigat​ional Oncology Compound, is Granted Orphan Drug Designatio​n for Acute Myeloid Leukemia in the US and EUBoehringer Ingelheim Pharmaceuticals, Inc. has announced that FDA and European Commission (EC) have granted Orphan Drug Designation to volasertib for acute myeloid leukemia (AML). Volasertib is cur2014/4/21
-
Newly minted GlaxoSmithKline diabetes drug faces formidable foes in GLP-1 marketThere's a new kid on the diabetes block. GlaxoSmithKline's ($GSK) albiglutide, now dubbed Tanzeum for the U.S. market, nabbedFDAapproval Tuesday. Now, the drug will go up against a triad of other GL2014/4/21
-
BioAlliance Pharma and Topotarget join forces to create new orphan oncology companyBioAlliance Pharma and Topotarget have announced a merger agreement with an aim to create an orphan oncology company with increased scale and a highly complementary pipeline of late-stage products tar2014/4/18
-
FDA approves GSK's Tanzeum injection for type 2 diabetes treatmentThe US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) Tanzeum (albiglutide) subcutaneous injection to improve glycaemic control, along with diet and exercise, in adults with t2014/4/18
-
Janssen's prostate cancer drug Zytiga now available in Trinidad and TobagoThe Chemistry, Food & Drugs Division of the Trinidad and Tobago Ministry of Health has approved Janssen's first orally administered androgen synthesis inhibitor (testosterone) medication 'Abirater2014/4/17
-
Merck obtains FDA approval for grass pollen allergy drugMerck has obtained approval from the US Food and Drug Administration (FDA) for its Grastek (Timothy grass pollen allergen extract) sublingual tablet as immunotherapy for treatment of grass pollen-indu2014/4/17
-
Astellas European Foundation awards 2014 urology grant to Austrian and Swiss researchersThe Astellas European Foundation has awarded $150,000 under the 2014 Functional Urology and Uro-Gynaecology Grant to Dr Marianne Gamper for conducting a study, which will be undertaken in Austria and2014/4/16